263 related articles for article (PubMed ID: 12417967)
1. The relationship between dopamine D2 receptor occupancy and the vacuous chewing movement syndrome in rats.
Turrone P; Remington G; Kapur S; Nobrega JN
Psychopharmacology (Berl); 2003 Jan; 165(2):166-71. PubMed ID: 12417967
[TBL] [Abstract][Full Text] [Related]
2. Electron spin resonance spectroscopy reveals alpha-phenyl-N-tert-butylnitrone spin-traps free radicals in rat striatum and prevents haloperidol-induced vacuous chewing movements in the rat model of human tardive dyskinesia.
Rogoza RM; Fairfax DF; Henry P; N-Marandi S; Khan RF; Gupta SK; Mishra RK
Synapse; 2004 Dec; 54(3):156-63. PubMed ID: 15452862
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of within-day continuous vs. transient dopamine D2 receptor occupancy in the development of vacuous chewing movements (VCMs) in rats.
Turrone P; Remington G; Kapur S; Nobrega JN
Neuropsychopharmacology; 2003 Aug; 28(8):1433-9. PubMed ID: 12838271
[TBL] [Abstract][Full Text] [Related]
4. Reversal of haloperidol-induced tardive vacuous chewing movements and supersensitive somatodendritic serotonergic response by buspirone in rats.
Haleem DJ; Samad N; Haleem MA
Pharmacol Biochem Behav; 2007 May; 87(1):115-21. PubMed ID: 17498786
[TBL] [Abstract][Full Text] [Related]
5. Glycine and D-cycloserine attenuate vacuous chewing movements in a rat model of tardive dyskinesia.
Shoham S; Mazeh H; Javitt DC; Heresco-Levy U
Brain Res; 2004 Apr; 1004(1-2):142-7. PubMed ID: 15033429
[TBL] [Abstract][Full Text] [Related]
6. Alterations in mRNA levels of D2 receptors and neuropeptides in striatonigral and striatopallidal neurons of rats with neuroleptic-induced dyskinesias.
Egan MF; Hurd Y; Hyde TM; Weinberger DR; Wyatt RJ; Kleinman JE
Synapse; 1994 Nov; 18(3):178-89. PubMed ID: 7531873
[TBL] [Abstract][Full Text] [Related]
7. Ultrastructural correlates of haloperidol-induced oral dyskinesias in rat striatum.
Roberts RC; Gaither LA; Gao XM; Kashyap SM; Tamminga CA
Synapse; 1995 Jul; 20(3):234-43. PubMed ID: 7570355
[TBL] [Abstract][Full Text] [Related]
8. Excitatory mechanisms in neuroleptic-induced vacuous chewing movements (VCMs): possible involvement of calcium and nitric oxide.
Naidu PS; Kulkarni SK
Behav Pharmacol; 2001 Jun; 12(3):209-16. PubMed ID: 11485057
[TBL] [Abstract][Full Text] [Related]
9. The vacuous chewing movement (VCM) model of tardive dyskinesia revisited: is there a relationship to dopamine D(2) receptor occupancy?
Turrone P; Remington G; Nobrega JN
Neurosci Biobehav Rev; 2002 May; 26(3):361-80. PubMed ID: 12034136
[TBL] [Abstract][Full Text] [Related]
10. Haloperidol versus risperidone on rat "early onset" vacuous chewing.
Marchese G; Bartholini F; Casu MA; Ruiu S; Casti P; Congeddu E; Tambaro S; Pani L
Behav Brain Res; 2004 Feb; 149(1):9-16. PubMed ID: 14739005
[TBL] [Abstract][Full Text] [Related]
11. Continuous but not intermittent olanzapine infusion induces vacuous chewing movements in rats.
Turrone P; Remington G; Kapur S; Nobrega JN
Biol Psychiatry; 2005 Feb; 57(4):406-11. PubMed ID: 15705357
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological and neurochemical differences between acute and tardive vacuous chewing movements induced by haloperidol.
Egan MF; Hurd Y; Ferguson J; Bachus SE; Hamid EH; Hyde TM
Psychopharmacology (Berl); 1996 Oct; 127(4):337-45. PubMed ID: 8923569
[TBL] [Abstract][Full Text] [Related]
13. Neurochemical changes in the entopeduncular nucleus and increased oral behavior in rats treated subchronically with clozapine or haloperidol.
Yu J; Källström L; Wiesel FA; Johnson AE
Synapse; 1999 Dec; 34(3):192-207. PubMed ID: 10523757
[TBL] [Abstract][Full Text] [Related]
14. The effect of chronic haloperidol treatment on dendritic spines in the rat striatum.
Kelley JJ; Gao XM; Tamminga CA; Roberts RC
Exp Neurol; 1997 Aug; 146(2):471-8. PubMed ID: 9270058
[TBL] [Abstract][Full Text] [Related]
15. Autoradiographic mapping of mu opioid receptor changes in rat brain after long-term haloperidol treatment: relationship to the development of vacuous chewing movements.
Sasaki T; Kennedy JL; Nobrega JN
Psychopharmacology (Berl); 1996 Nov; 128(1):97-104. PubMed ID: 8944412
[TBL] [Abstract][Full Text] [Related]
16. Failure to down regulate NMDA receptors in the striatum and nucleus accumbens associated with neuroleptic-induced dyskinesia.
Hamid EH; Hyde TM; Baca SM; Egan MF
Brain Res; 1998 Jun; 796(1-2):291-5. PubMed ID: 9689480
[TBL] [Abstract][Full Text] [Related]
17. Involvement of adenosinergic receptor system in an animal model of tardive dyskinesia and associated behavioural, biochemical and neurochemical changes.
Bishnoi M; Chopra K; Kulkarni SK
Eur J Pharmacol; 2006 Dec; 552(1-3):55-66. PubMed ID: 17064683
[TBL] [Abstract][Full Text] [Related]
18. Differential role of dopamine D1 and D2 receptors in isoniazid-induced vacuous chewing movements.
Naidu PS; Kulkarni SK
Methods Find Exp Clin Pharmacol; 2000 Dec; 22(10):747-51. PubMed ID: 11346896
[TBL] [Abstract][Full Text] [Related]
19. Enhanced 5-HT2C receptor signaling is associated with haloperidol-induced "early onset" vacuous chewing in rats: implications for antipsychotic drug therapy.
Wolf WA; Bieganski GJ; Guillen V; Mignon L
Psychopharmacology (Berl); 2005 Oct; 182(1):84-94. PubMed ID: 15986194
[TBL] [Abstract][Full Text] [Related]
20. Parallels between behavioral and neurochemical variability in the rat vacuous chewing movement model of tardive dyskinesia.
Bachus SE; Yang E; McCloskey SS; Minton JN
Behav Brain Res; 2012 Jun; 231(2):323-36. PubMed ID: 22503783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]